Fox Chase cancer Center — Philadelphia, Pennsylvania

Fox Chase cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19111.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Fox Chase cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Other Solid Tumors, Adult.

Sponsors: Cogent Biosciences, Inc., Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Cell Genesys.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase cancer Center?

Fox Chase cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase cancer Center conducted?

Fox Chase cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Other Solid Tumors, Adult.

Is Fox Chase cancer Center accredited by Crixeo Health?

Fox Chase cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.